Among the many goals of OEIS are to enhance the safety, quality, and efficacy of outpatient and office-based interventional procedures. To achieve that goal, the society plans to develop and promote standards of care, appropriateness criteria, safety, and outcomes measures unique to the office-based setting. The society plans to promote research and education regarding medical, economic, and longitudinal management issues relating to these procedures. It will also provide a forum to collaborate and share best-practice experiences among other practitioners. In these ways, the OEIS plans to enhance the endovascular and interventional fields by leading with innovations, product development, and modes of care delivery.
With the nationally changing health care landscape, the society will help bring together experiences and thought leaders that are innovating ways to deliver cost-effective, quality care. Cost containment remains a core focus in outpatient interventional suites. The model of more directly aligning providers with patients’ best interests and high-quality care continues to drive expansion of these centers. Payers continue to support development of these centers because it is cost effective. To date, there remains a significant geographic treatment gap in the United States in regards to offering endovascular therapies to peripheral arterial disease patients with critical limb ischemia.1 Executed properly, office-based suites are positioned to positively impact patients’ access to affordable, quality care at a local level.
With a collective voice on behalf of patients and physicians, the OEIS will be a strong advocate with payers, legislative bodies, and industry. A poignant example of this need occurred this past summer, as Centers for Medicare & Medicaid Services (CMS) announced the 2014 Proposed Rule for the Medicare Physician’s Fee Schedule, which included steep pay reductions for peripheral arterial disease and other procedures. This proposed reduction in payment and new payment system would have a significant impact on the ability to provide services in the office-based setting and implications for patient access and choice. A coalition effort from many individuals and organizations was successful in educating CMS to not finalize the Rule.2
In the future, further organized efforts will be needed to partner with other societies, service organizations, and industry to continue to educate CMS and other payers about the high value of office- and outpatient-based interventional services for patients and health care systems. OEIS will take a central and leading role in these efforts on state and national levels.